Clinical Trial Results:
An eight-week, double-blind study to evaluate the efficacy, safety, and tolerability of two fixed doses of saredutant (100 mg and 30 mg) once daily in combination with paroxetine 20 mg once daily compared to saredutant placebo in combination with paroxetine 20 mg once daily in patients with major depressive disorder
Summary
|
|
EudraCT number |
2007-003863-31 |
Trial protocol |
DE EE |
Global completion date |
27 Feb 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Nov 2016
|
First version publication date |
17 Nov 2016
|
Other versions |
|
Summary report(s) |
EFC10438 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.